NeuroNova, Newron deal

Newron will acquire neurogenesis company NeuroNova in an amended stock deal valuing NeuroNova at €15.5 million ($20 million). NeuroNova shareholders will be issued 2.4 million shares of Newron, representing a 21.3% stake in the company. The deal, which Newron's board approved, is expected to close by year end. ...